1-20 of 72
Itaru Matsumura
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Thrombotic and Bleeding Events in Japanese Adolescent and Young Adult PV and ET: Results from Japanese Multicenter Retrospective Study

Yuka Sugimoto, Keiki Nagaharu, Eiko Oya, Kohshi Ohishi, Isao Tawara, Tomoki Ito, Akihiko Gotoh, Mika Nakamae, Fumihiko Kimura, Michiaki Koike, Keita Kirito, Hideho Wada, Kensuke Usuki, Takayuki Tanaka, Takehiko Mori, Satoshi Wakita, Toshiki I Saito, Akiko Kada, Akiko M Saito, Kazuya Shimoda, Toshio Kurokawa, Akihiro Tomita, Yoko Edahiro, Yoshinori Hashimoto, Hitoshi Kiyoi, Koichi Akashi, Itaru Matsumura, Katsuto Takenaka, Norio Komatsu
Journal: Blood
Blood (2023) 142 (Supplement 1): 1831.
https://doi.org/10.1182/blood-2023-180561
Published: 2023
Journal Articles

Real-World Data in a Prospective Clinical Observation Study for Newly Diagnosed Adult Acute Lymphoblastic Leukemia, the JALSG ALL-CS-12 : Advanced Age Is a Poor Prognostic Factor

Yoshihiro Hatta, Fumihiko Hayakawa, Etsuko Yamazaki, Tohru Murayama, Takeshi Saito, Satoru Takada, Nobuaki Dobashi, Shuichi Ota, Yasuhisa Yokoyama, Masatsugu Tanaka, Shinya Sato, Shigeki Ohtake, Emiko Sakaida, Yoshinobu Maeda, Takahiro Yamauchi, Itaru Matsumura, Yasushi Miyazaki, Hitoshi Kiyoi
Journal: Blood
Blood (2023) 142 (Supplement 1): 4199.
https://doi.org/10.1182/blood-2023-178332
Published: 2023
Journal Articles

The Outcomes of Pregnancies in Japanese Patients with CML in the TKI Era; A Result of Nationwide Survey

Takeshi Kondo, Eri Matsuki, Tomoiku Takaku, Masaya Okada, Kazunori Murai, Chikashi Yoshida, Naoki Watanabe, Naoto Takahashi, Shinya Kimura, Itaru Matsumura
Journal: Blood
Blood (2023) 142 (Supplement 1): 1802.
https://doi.org/10.1182/blood-2023-174169
Published: 2023
Journal Articles

Risk Stratified Therapy with Nelarabine and Intensified Administration of L-Asparaginase for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia in Adolescents and Young Adults (JPLSG T-11/JALSG T-ALL-211-U): An Intergroup Phase 2 Study

Yoshihiro Hatta, Atsushi Sato, Akiko Kada, Akiko Moriya Saito, Fumihiko Hayakawa, Arata Watanabe, Tatsuhiro Sakamoto, Katsuhiro Miura, Yoshifumi Shimizu, Junya Kanda, Yasushi Onishi, Noboru Asada, Yasuhiro Okamoto, Chihaya Imai, Koichi Oshima, Katsuyoshi Koh, Atsushi Manabe, Keizo Horibe, Hitoshi Kiyoi, Itaru Matsumura, Yasushi Miyazaki
Journal: Blood
Blood (2022) 140 (Supplement 1): 124–126.
https://doi.org/10.1182/blood-2022-156613
Published: 2022
Journal Articles

Efficacy and Safety of Long-Term Romiplostim Use for Refractory Aplastic Anemia

Kinuko Mitani, Jong Wook Lee, Jun Ho Jang, Yoshiaki Tomiyama, Koji Miyazaki, Koji Nagafuji, Kensuke Usuki, Nobuhiko Uoshima, Tomoaki Fujisaki, Hiroshi Kosugi, Itaru Matsumura, Ko Sasaki, Masahiro Kizaki, Masashi Sawa, Michihiro Hidaka, Naoki Kobayashi, Satoshi Ichikawa, Yuji Yonemura, Kenta Murotani, Mami Shimizu, Akira Matsuda, Keiya Ozawa, Shinji Nakao
Journal: Blood
Blood (2022) 140 (Supplement 1): 8634–8637.
https://doi.org/10.1182/blood-2022-162895
Published: 2022
Journal Articles

Poor Prognostic Combination of Additional Chromosomal Abnormalities in Ph + ALL : JALSG Ph+ALL TKI- SCT Study

Satoshi Nishiwaki, Isamu Sugiura, Shin Fujisawa, Yoshihiro Hatta, Noriko Doki, Shingo Kurahashi, Yasunori Ueda, Nobuaki Dobashi, Tomoya Maeda, Yasuhiro Taniguchi, Masatsugu Tanaka, Shinichi Kako, Tatsuo Ichinohe, Takahiro Fukuda, Yoshiko Atsuta, Shigeki Ohtake, Yuichi Ishikawa, Hitoshi Kiyoi, Itaru Matsumura, Yasushi Miyazaki
Journal: Blood
Blood (2022) 140 (Supplement 1): 6030–6032.
https://doi.org/10.1182/blood-2022-165864
Published: 2022
Journal Articles

Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations

Clinical Trials & Observations
Takahiko Yasuda, Masashi Sanada, Masahito Kawazu, Shinya Kojima, Shinobu Tsuzuki, Hiroo Ueno, Eisuke Iwamoto, Yuka Iijima-Yamashita, Tomomi Yamada, Takashi Kanamori, Rieko Nishimura, Yachiyo Kuwatsuka, Satoru Takada, Masatsugu Tanaka, Shuichi Ota, Nobuaki Dobashi, Etsuko Yamazaki, Asao Hirose, Tohru Murayama, Masahiko Sumi, Shinya Sato, Naoyuki Tange, Yukinori Nakamura, Yuna Katsuoka, Emiko Sakaida, Toyotaka Kawamata, Hiroatsu Iida, Yuichi Shiraishi, Yasuhito Nannya, Seishi Ogawa, Masafumi Taniwaki, Norio Asou, Yoshihiro Hatta, Hitoshi Kiyoi, Itaru Matsumura, Keizo Horibe, Hiroyuki Mano, Tomoki Naoe, Yasushi Miyazaki, Fumihiko Hayakawa
Journal: Blood
Blood (2022) 139 (12): 1850–1862.
https://doi.org/10.1182/blood.2021011921
Published: 2022
Includes: Supplemental data
Journal Articles

Efficacy and Safety of Bosutinib in Japanese Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: Final 3-Year Results of a Phase 2 Study

Takaaki Ono, Masayuki Hino, Itaru Matsumura, Shin Fujisawa, Kenichi Ishizawa, Emiko Sakaida, Naohiro Sekiguchi, Chiho Ono, Mana Aizawa, Yusuke Tanetsugu, Yuichiro Koide, Naoto Takahashi
Journal: Blood
Blood (2021) 138 (Supplement 1): 2557.
https://doi.org/10.1182/blood-2021-145164
Published: 2021
Journal Articles

Impact of Nelarabine, Intensive L-Asparaginase, and Protracted Intrathecal Therapy on Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group and the Japan Adult Leukemia Study Group

Atsushi Sato, Yoshihiro Hatta, Chihaya Imai, Koichi Oshima, Yasuhiro Okamoto, Takao Deguchi, Yoshiko Hashii, Takashi Fukushima, Toshinori Hori, Nobutaka Kiyokawa, Motohiro Kato, Shoji Saito, Kenichi Anami, Tatsuhiro Sakamoto, Akiko Kada, Akiko M Saito, Atsushi Manabe, Hitoshi Kiyoi, Itaru Matsumura, Keizo Horibe, Katsuyoshi Koh, Yasushi Miyazaki, Arata Watanabe
Journal: Blood
Blood (2021) 138 (Supplement 1): 3393.
https://doi.org/10.1182/blood-2021-149110
Published: 2021
Journal Articles

Outcomes of Transplant-Eligible Patients with Myelodysplastic Syndrome-Refractory Anemia with Excess Blasts Registered in a Prospective Observational Study: The JALSG-CS11-MDS-SCT

Noriharu Nakagawa, Ken Ishiyama, Kensuke Usuki, Satoru Takada, Tatsuki Tomikawa, Hiroshi Handa, Yuna Katsuoka, Daiki Hirano, Nobuo Sezaki, Masahiko Sumi, Shin Fujisawa, Yasuhiro Taniguchi, Takuro Yoshimura, Eiichi Ohtsuka, Ken Takase, Youko Suehiro, Shuichi Ota, Tomohiro Kajiguchi, Tomoya Maeda, Masahide Yamamoto, Shigeki Ohtake, Akira Katsumi, Hitoshi Kiyoi, Itaru Matsumura, Yasushi Miyazaki
Journal: Blood
Blood (2021) 138 (Supplement 1): 2925.
https://doi.org/10.1182/blood-2021-147587
Published: 2021
Journal Articles

Nilotinib and Dasatinib Evoked Distinct Immune Effects during Tfr Phase of Each Discontinuation Trial

Yuki Fujioka, Naoto Takahashi, Shigeki Ohtake, Yoshiko Atsuta, Yosuke Minami, Noriyoshi Iriyama, Hitoshi Kiyoi, Yasushi Miyazaki, Itaru Matsumura
Journal: Blood
Blood (2021) 138 (Supplement 1): 3580.
https://doi.org/10.1182/blood-2021-147312
Published: 2021
Journal Articles

Nilotinib Vs. Dasatinib in Achieving MR 4.5 for Newly Diagnosed Chronic Myeloid Leukemia: Results of the Prospective Randomized Phase 3 Study, JALSG CML212

Itaru Matsumura, MDPhD, Shigeki Ohtake, MD PhD, Yoshiko Atsuta, MD PhD, Mio Kurata, Yosuke Minami, MDPhD, Naoto Takahashi, MD PhD, Chiaki Nakaseko, MDPhD, Noriyoshi Iriyama, MD PhD, Katsumichi Fujimaki, MD, Kazuhiko Kakihana, MD PhD, Yoji Ogasawara, Takaaki ONO, MD PhD, Masaya Okada, MD, Tetsuzo Tauchi, MD PhD, Toshihiro Miyamoto, MD PhD, Kazunori Ohnishi, MD, Emiko Sakaida, MDPhD, Shin Fujisawa, MD, Yukio Kobayashi, MDDSc, Norio Asou, MDPhD, Hitoshi Kiyoi, MD PhD, Yasushi Miyazaki, MD PhD, Tomoki Naoe, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-134168
Published: 2020
Journal Articles

ASXL1 Mutations Predict a Poor Response to Darbepoetin Alfa in Anemic Patients with Low-Risk MDS: A Multicenter, Phase II Study

Hitoshi Hanamoto, Yasuyoshi Morita, Motoshi Ichikawa, Yasuhito Nannya, MD PhD, Hirohiko Shibayama, MD PhD, Yoshinobu Maeda, MD, Tomoko Hata, Toshihiro Miyamoto, MD PhD, Hiroshi Kawabata, MD PhD, Kazuto Takeuchi, Hiroko Tanaka, Junji Kishimoto, Satoru Miyano, PhD, Itaru Matsumura, MDPhD, Seishi Ogawa, MD PhD, Koichi Akashi, MD PhD, Yuzuru Kanakura, MD PhD, Kinuko Mitani
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–29.
https://doi.org/10.1182/blood-2020-134483
Published: 2020
Journal Articles

The Optimal Treatment Strategy for Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Complete Remission in the Era of High-Intensity Chemotherapy

Shinichi Kako, MD, Fumihiko Hayakawa, MD, PhD, Kiyotoshi Imai, Junji Tanaka, MD PhD, Shuichi Mizuta, Satoshi Nishiwaki, MD PhD, Heiwa Kanamori, MD PhD, Noriko Doki, MD PhD, Naoyuki Uchida, MD PhD, Kazuhiro Ikegame, MD PhD, Takahiro Fukuda, Tatsuo Ichinohe, Shuichi Ota, Yoshinori Tanaka, MD, Tohru Murayama, MD PhD, Shingo Kurahashi, MD PhD, Toru Sakura, Noriko Usui, MD PhD, Shigeki Ohtake, MD PhD, Hitoshi Kiyoi, MD PhD, Itaru Matsumura, MD PhD, Yasushi Miyazaki, MD PhD, Yoshiko Atsuta, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4589.
https://doi.org/10.1182/blood-2019-126012
Published: 2019
Journal Articles

Prognostic Effects of Pretreatment Statuses at Diagnosis in Patients with Chronic Myeloid Leukemia: Results of the New Target Observational Study 1

Takaaki ONO, MD PhD, Naoto Takahashi, MD PhD, Masahiro Kizaki, MD, Tatsuya Kawaguchi, MD, Ritsuro Suzuki, MD PhD, Kazuhito Yamamoto, Kazunori Ohnishi, MD, Tomoki Naoe, MD PhD, Itaru Matsumura, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4149.
https://doi.org/10.1182/blood-2019-122092
Published: 2019
Journal Articles

Prospective Evaluation of Allogeneic HSCT at the First Remission for Younger Adults with FLT3 -ITD Positive Acute Myeloid Leukemia: The JALSG AML209-FLT3-SCT Study

Naomi Kawashima, MD PhD, Yuichi Ishikawa, MD PhD, Yoshiko Atsuta, MD PhD, Masashi Sawa, MD PhD, Yukiyasu Ozawa, MD PhD, Masaki Hayashi, MD, Akio Kohno, MD PhD, Akihiro Tomita, MD PhD, Tomoya Maeda, MD PhD, Emiko Sakaida, MD PhD, Kensuke Usuki, MD PhD, Maki Hagihara, MD PhD, Heiwa Kanamori, MD PhD, Hiroshi Matsuoka, MD PhD, Miki Kobayashi, MD PhD, Norio Asou, MD PhD, Shigeki Ohtake, MD PhD, Itaru Matsumura, MD PhD, Yasushi Miyazaki, MD PhD, Tomoki Naoe, MD PhD, Hitoshi Kiyoi, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1328.
https://doi.org/10.1182/blood-2019-124394
Published: 2019
Journal Articles

Second-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia with Additional Chromosomal Abnormalities

Naoto Takahashi, MD PhD, Tomoko Yoshioka, MD, Masahiro Kizaki, MD, Tatsuya Kawaguchi, MD, Ritsuro Suzuki, MD PhD, Kazuhito Yamamoto, Kazunori Ohnishi, MD, Tomoki Naoe, MD PhD, Itaru Matsumura, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1640.
https://doi.org/10.1182/blood-2019-123337
Published: 2019
Journal Articles

Phase 2 Study of Bosutinib in Japanese Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Naoto Takahashi, MD PhD, Itaru Matsumura, MD PhD, Shin Fujisawa, MD, Kenichi Ishizawa, MD PhD, Takaaki ONO, MD PhD, Emiko Sakaida, MD PhD, Naohiro Sekiguchi, MD PhD, Yusuke Tanetsugu, Kei Fukuhara, Masayuki Ohkura, Yuichiro Koide, Masayuki Hino, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4159.
https://doi.org/10.1182/blood-2019-121809
Published: 2019
Journal Articles

Prospective Evaluation of Prognostic Relevance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: Results from the JALSG CBF-AML209-KIT Study

Naomi Kawashima, MD, Yuichi Ishikawa, MD PhD, Yoshiko Atsuta, MD PhD, Isamu Sugiura, MD, Masashi Sawa, MD PhD, Nobuaki Dobashi, MD, Hisayuki Yokoyama, MD PhD, Noriko Doki, MD PhD, Akihiro Tomita, MD PhD, Toru Kiguchi, MD PhD, Shiro Koh, MD, Heiwa Kanamori, MD PhD, Noriyoshi Iriyama, MD PhD, Akio Kohno, MD, Yukiyoshi Moriuchi, MD, Noboru Asada, MD PhD, Daiki Hirano, MD, Kazuto Togitani, MD, Toru Sakura, PhD MD, Maki Hagihara, MD PhD, Tatsuki Tomikawa, MD PhD, Yasuhisa Yokoyama, MDPhD, Norio Asou, MDPhD, Shigeki Ohtake, MD PhD, Itaru Matsumura, MD, Yasushi Miyazaki, MD PhD, Tomoki Naoe, MD PhD, Hitoshi Kiyoi, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 438.
https://doi.org/10.1182/blood-2018-99-113931
Published: 2018
Journal Articles

Efficacy and Safety of Tyrosine Kinase Inhibitors for Treatment of Newly Diagnosed Chronic Myeloid Leukemia: Results Using Data Obtained with the New Target System from the Japanese Registry

Naoto Takahashi, MD, Masahiro Kizaki, MDPhD, Masatomo Miura, PhD, Tatsuya Kawaguchi, MD PhD, Ritsuro Suzuki, MD PhD, Kazuhito Yamamoto, MDPhD, Kazunori Ohnishi, MD PhD, Itaru Matsumura, MD, Tomoki Naoe, MD PhD, Koichi Akashi, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1751.
https://doi.org/10.1182/blood-2018-99-111680
Published: 2018